Cytomegalovirus retinitis after central retinal vein occlusion in a patient on systemic immunosuppression: Does venooclusive disease predispose to cytomegalovirus retinitis in patients already at risk?

John D. Welling, Ahmad B. Tarabishy, John B. Christoforidis

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Cytomegalovirus (CMV) retinitis remains the most common opportunistic ocular infection in immunocompromised patients. Patients with immunocompromising diseases, such as acquired immunodeficiency syndrome, inherited immunodeficiency states, malignancies, and those on systemic immunosuppressive therapy, are known to be at risk. Recently, it has been suggested that patients undergoing intravitreal injection of immunosuppressive agents may also be predisposed. One previous case report speculated that there may be an additional risk for CMV retinitis in acquired immunodeficiency syndrome patients with venoocclusive disease. This case study presents a case of CMV retinitis following central retinal vein occlusion in a patient on systemic immunosuppressants.

Original languageEnglish (US)
Pages (from-to)601-603
Number of pages3
JournalClinical Ophthalmology
Volume6
Issue number1
DOIs
StatePublished - Apr 17 2012

Keywords

  • Central retinal vein occlusion
  • Cytomegalovirus retinitis
  • Immunosuppression
  • Risk factor
  • Solid organ transplant
  • Venous stasis

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Cytomegalovirus retinitis after central retinal vein occlusion in a patient on systemic immunosuppression: Does venooclusive disease predispose to cytomegalovirus retinitis in patients already at risk?'. Together they form a unique fingerprint.

  • Cite this